| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |